182 related articles for article (PubMed ID: 35714907)
21. Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation.
Ureshino H; Shindo T; Sano H; Kubota Y; Ando T; Kidoguchi K; Kusaba K; Itamura H; Kojima H; Kusunoki Y; Miyazaki Y; Kojima K; Tanaka H; Saji H; Oshima K; Kimura S
Int J Hematol; 2020 May; 111(5):733-738. PubMed ID: 31873846
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
23. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
Front Immunol; 2018; 9():1841. PubMed ID: 30154788
[TBL] [Abstract][Full Text] [Related]
24. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH
Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556
[TBL] [Abstract][Full Text] [Related]
26. Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Mushtaq MU; Shahzad M; Shah AY; Chaudhary SG; Zafar MU; Anwar I; Neupane K; Khalid A; Ahmed N; Bansal R; Balusu R; Singh AK; Abhyankar SH; Callander NS; Hematti P; McGuirk JP
Front Immunol; 2022; 13():1005031. PubMed ID: 36263054
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.
Pical-Izard C; Crocchiolo R; Granjeaud S; Kochbati E; Just-Landi S; Chabannon C; Frassati C; Picard C; Blaise D; Olive D; Fauriat C
Biol Blood Marrow Transplant; 2015 Mar; 21(3):429-39. PubMed ID: 25579888
[TBL] [Abstract][Full Text] [Related]
28. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.
Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J
Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658
[TBL] [Abstract][Full Text] [Related]
30. Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graft-versus-Host Effects.
Jaiswal SR; Chakraborty S; Lakhchaura R; Shashi P; Mehta A; Soni M; Chakrabarti S
Transplant Cell Ther; 2021 Feb; 27(2):144-151. PubMed ID: 33830023
[TBL] [Abstract][Full Text] [Related]
31. Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Björklund AT; Clancy T; Goodridge JP; Béziat V; Schaffer M; Hovig E; Ljunggren HG; Ljungman PT; Malmberg KJ
J Immunol; 2016 Feb; 196(3):1400-11. PubMed ID: 26746188
[TBL] [Abstract][Full Text] [Related]
32. Persistence of KIR
Di Vito C; Coianiz N; Calvi M; Terzoli S; Zaghi E; Puccio S; Frigo A; Mariotti J; De Philippis C; Mannina D; Sarina B; Mineri R; Le-Trilling VTK; Trilling M; Castagna L; Bramanti S; Santoro A; Mavilio D
Front Immunol; 2023; 14():1266051. PubMed ID: 38268918
[TBL] [Abstract][Full Text] [Related]
33. Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.
Haroun-Izquierdo A; Lanuza PM; Pfefferle A; Netskar H; Ask EH; Törlén J; Björklund A; Sohlberg E; Malmberg KJ
Transplant Cell Ther; 2023 Jun; 29(6):376.e1-376.e11. PubMed ID: 36966873
[TBL] [Abstract][Full Text] [Related]
34. Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.
de Witte MA; Sarhan D; Davis Z; Felices M; Vallera DA; Hinderlie P; Curtsinger J; Cooley S; Wagner J; Kuball J; Miller JS
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1152-1162. PubMed ID: 29505821
[TBL] [Abstract][Full Text] [Related]
35. Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation.
Pradier A; Cordey S; Zanella MC; Melotti A; Wang S; Mamez AC; Chalandon Y; Masouridi-Levrat S; Kaiser L; Simonetta F; Vu DL
Front Immunol; 2022; 13():1060886. PubMed ID: 36713419
[TBL] [Abstract][Full Text] [Related]
36. Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
Shaffer BC; Le Luduec JB; Forlenza C; Jakubowski AA; Perales MA; Young JW; Hsu KC
Biol Blood Marrow Transplant; 2016 Apr; 22(4):705-709. PubMed ID: 26772158
[TBL] [Abstract][Full Text] [Related]
37. Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.
Troullioud Lucas AG; Lindemans CA; Bhoopalan SV; Dandis R; Prockop SE; Naik S; Keerthi D; de Koning C; Sharma A; Nierkens S; Boelens JJ
Cytotherapy; 2023 Sep; 25(9):977-985. PubMed ID: 37330731
[TBL] [Abstract][Full Text] [Related]
38. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
39. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease.
Dunbar EM; Buzzeo MP; Levine JB; Schold JD; Meier-Kriesche HU; Reddy V
Haematologica; 2008 Dec; 93(12):1852-8. PubMed ID: 18945751
[TBL] [Abstract][Full Text] [Related]
40. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Martínez C; Urbano-Ispizua A; Rozman C; Marín P; Rovira M; Sierra J; Montfort N; Carreras E; Montserrat E
Exp Hematol; 1999 Mar; 27(3):561-8. PubMed ID: 10089920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
